Peter J. McDonnell

Board Director

Director

US·SEC (Form 4)

Aerie Pharmaceuticals Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €118k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Peter J. McDonnell: trading record in brief

Peter J. McDonnell is a declared insider of Aerie Pharmaceuticals Inc (board member), with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 17 June 2021 to 21 November 2022.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 21 November 2022, reports a transaction of €118k in Aerie Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.